Hughes syndrome crosses boundaries

Autoimmunity Reviews

Volumn 1, Issue 1-2, 2002, Pages 43-48

  Ruiz Irastorza, Guillermo ^a,b   Khamashta, Munther A ^a   Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

Anticardiolipin antibodies; Anticoagulation; Antiphospholipid antibodies; Antiphospholipid syndrome; APS: antiphospholipid syndrome; Migraine; Miscarriage; Multiple sclerosis; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBODY; ANTICOAGULANT AGENT; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; HEPARIN; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN; PLACEBO; PROTEIN C; PROTHROMBIN; WARFARIN;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BLEEDING; CLINICAL CHEMISTRY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CULTURE MEDIUM; DEMYELINATING DISEASE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS WASTAGE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOASSAY; INCIDENCE; LABORATORY TEST; MEDICAL EXAMINATION; MIGRAINE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; OBSTETRICS; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY COMPLICATION; RECURRENT DISEASE; REVIEW; SERUM; SPINAL CORD DISEASE; SPONTANEOUS ABORTION; STANDARDIZATION; THROMBOCYTOPENIA; THROMBOPHILIA; THROMBOSIS; VALIDATION PROCESS; VEIN THROMBOSIS; ANIMAL; BLOOD; FEMALE; PREGNANCY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ABORTION, SPONTANEOUS; ANIMALS; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; PREGNANCY; THROMBOSIS;

EID: 0141888080     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(01)00005-2     Document Type: Review

References (40)

1. Hughes G.R.V. The anticardiolipin syndrome. Clin Exp Rheumatol. 3:1985;285.
2. Alarcon-Segovia D., Deleze M., Oria C.V., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore). 68:1989;353-365.
3. Asherson R.A., Khamashta M.A., Ordi-Ros J., et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine. 68:1989;366-374.
4. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 42:1999;1309-1311.
5. Lockshin M.D., Sammaritano L.R., Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum. 43:2000;440-443.
6. Pierangeli S.S., Gharavi A.E., Harris E.N. Anticardiolipin testing. Khamashta M.A. Hughes' syndrome. 2000;205-213 Springer, London.
7. Mackie I.J., Donohoe S., Machin S.J. Lupus anticoagulant measurement. Khamashta M.A. Hughes' syndrome. 2000;214-224 Springer, London.
8. Brandt J.T., Tripplet D.A., Alving B., Scharrer I. Criteria for the diagnosis of lupus anticoagulant: an update. Throm Haemost. 74:1995;1185-1190.
9. Roubey R.A.S. Antiphospholipid antibody-negative syndrome-other phospholipids. Khamashta M.A. Hughes' syndrome. 2000;253-260 Springer, London.
10. Lee R.M., Emlen W., Scott J.R., Branch D.W., Silver R.M. Anti-β2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Am J Obstet Gynecol. 181:1999;642-648.
11. Krnic-Barrie S., O'Connor C.R., Looney S.W., Pierangeli S.S., Harris E.N. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Arch Intern Med. 157:1997;2101-2108.
12. Ruiz-Irastorza G., Khamashta M.A., Hughes G.R. Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: maternal and fetal complications and their management. Isr Med Assoc J. 2:2000;462-469.
13. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for stroke. Neurology 1993; 43: 2069-73.
14. Camerlingo M., Casto L., Censori B., et al. Anticardiolipin antibodies in acute non-hemorrhgic stroke seen within six hours after onset. Acta Neurol Scand. 92:1995;69-71.
15. 2- glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction. The Honolulu heart program. Stroke. 32:2001;1701-1706.
16. Ginsburg K.S., Liang M.H., Newcomer L., Goldhaber S.Z., Schur P.H., Hennekens C.H., Stampfer M.J. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 117:1992;997-1002.
17. Muir K.W., Squire I.B., Alwan W., Lees K.R. Anticardiolipin antibodies in an unselected stroke population. Lancet. 344:1994;452-456.
18. Ahmed E., Stegmayr B., Trifunovic J., Weinehall L., Hallmans G., Lefvert A.K. Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke. 31:2000;1289-1293.
19. Bushnell C.D., Goldstein L.B. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke. 31:2000;3067-3078.
20. Rosove M.H., Brewer P.M.C. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 117:1992;303-308.
21. Khamashta M.A., Cuadrado M.J., Mujic F., Taub N.A., Hunt B.J., Hughes G.R.V. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 332:1995;993-997.
22. Verro P., Levine S.R., Tietjen G.E. Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke. 29:1998;2245-2253.
23. Finazzi G., Brancaccio V., Moia M., et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry. Am J Med. 100:1996;530-536.
24. Scott T.F., Hess D., Brillman J. Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging. Arch Intern Med. 154:1994;917-920.
25. IJdo J.W., Conti-Kelly A.M., Greco P., Abedi M., Amos M., Provenzale J.M., Greco T.P. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus. 8:1999;109-115.
26. Karussis D., Leker R.R., Ashkenazi A., Abramsky O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol. 44:1998;629-634.
27. Cuadrado M.J., Khamashta M.A., Ballesteros A., Godfrey T., Simon M.J., Hughes G.R. Can neurologic manifestations of Hughes' (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore). 79:2000;57-68.
28. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 50:2001;121-127.
29. Ruiz-Irastorza G., Khamashta M.A. Warfarin for multiple sclerosis? Q J Med. 93:2000;497-499.
30. Navarrete M.G., Brey R.L., Levine S.R. Cerebral disease in the antiphospholipid syndrome. Khamashta M.A. Hughes' syndrome. 2000;43-58 Springer, London.
31. Tietjen G.E., Day M., Norris L., et al. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology. 50:1998;1433-1440.
32. Ruiz-Irastorza G., Khamashta M.A., Hughes G.R.V. Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome. Lupus. 10:2001;241-245.
33. Khamashta M.A. Management of thrombosis in the antiphospholipid syndrome. Khamashta M.A. Hughes' syndrome. 2000;391-396 Springer, London.
34. Ruiz-Irastorza G., Khamashta M., Hughes G. Treatment of the antiphospholipid syndrome in pregnancy. Scand J Rheumatol. 27:(suppl 107):1998;44-47.
35. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J. 314:1997;253-257.
36. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 174:1996;1584-1589.
37. Pattison N.S., Chamley L.W., Birdsall M., Zanderigo A.M., Liddel H.S., McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol. 183:2000;1008-1012.
38. Schulman S., Svenungsson E., Granqvist S. and the Duration of Anticoagulation Study Group. Anticardiolipin antibodies predict early recurrence in thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med. 104:1998;332-338.
39. Ruiz-Irastorza G., Khamashta M.A., Escudero A., Cuadrado M.J., Hunt B.J., Hughes G.R.V. Analysis of bleeding in patients with antiphospholipid syndrome treated with high-intensity anticoagulation (abstract). Lupus. 10:(suppl 1):2001;S8.
40. Castellino G., Cuadrado M.J., Godfrey T., Khamashta M.A., Hughes G.R.V. Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment. Ann Rheum Dis. 60:2001;527-530.